Last May, the British Medical Journal published a study showing that patients who took Actos for two years were twice as likely to get bladder cancer.
New York, New York (PRWEB) January 15, 2013
Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective drugs, has filed a lawsuit alleging that Actos caused bladder cancer in a Minnesota man. The suit was filed on November 16, 2012 in the U.S. District Court for the Western District of Louisiana, Lafayette Division (Case No. 6:12-cv-2903). This case is one of many cases pending in the Actos multidistrict litigation (MDL) entitled In Re: Actos (Pioglitazone) Products Liability Litigation (MDL No. 6:11-md-2299). Jerrold S. Parker, founding partner of Parker Waichman LLP, serves on the Plaintiff’s Steering Committee in the litigation. Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals USA, Inc. f/k/a Takeda Pharmaceuticals North America, Inc., Takeda Pharmaceutical Company Limited and Eli Lilly and Company has been named as Defendants.
According to the Complaint, the Plaintiff started taking Actos in 2011. Thereafter, he developed bladder cancer, allegedly due to using the drug. The lawsuit alleges that the Defendants made misrepresentations and omissions with regards to Actos and actively concealed its risks. The suit also alleges that there are several safer alternatives for treating Type 2 diabetes, and that the Plaintiff had not been adequately warned about the risks of using Actos. The Plaintiff is suing for a number of damages, including severe mental and physical pain and suffering, permanent injuries, emotional distress and economic loss due to medical expenses and living-related expenses due to a new lifestyle.
A growing body of research suggests that Actos is associated with an increased risk of bladder cancer. In June 2011, the FDA announced that the warning label on Actos would be updated to include this risk. The new label warns that using Actos for more than one year may significantly increase the risk of developing bladder cancer. Data is based on an ongoing, 10-year study conducted by Kaiser Permanente. Last May, the British Medical Journal published a study showing that patients who took Actos for two years were twice as likely to get bladder cancer. Yet another study, published last summer in the Canadian Medical Association Journal, found that use of Actos was linked to a 22 percent increased risk of developing bladder cancer.
Parker Waichman LLP continues to offer free legal consultations to victims of Actos injuries, including bladder cancer, heart problems, and eye injuries. If you or a loved one were diagnosed with bladder cancer after taking Actos, please contact their office by visiting yourlawyer.com. Free case evaluations are also available by calling 1 800 LAW INFO (1-800-529-4636).
Parker Waichman LLP
Gary Falkowitz, Managing Attorney